Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection

Authors

  • Negar Motayagheni Institute for Regenerative Medicine, Wake Forest School of Medicine , Winston Salem, NC, USA.
  • Sheshanna Phan Division of Molecular Medicine, Department of Anesthesiology’ UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
  • Ala Nozari Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Anthony Atala Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.

DOI:

https://doi.org/10.18433/J30D2V

Abstract

Efforts to develop a treatment for bupivacaine cardiotoxicity led to the discovery that Intralipid, a popular brand of intravenous lipid emulsion, could be used not only as an effective treatment for anesthetic-induced cardiac arrest, but also as a means of reversing many other toxicities. Contradictory data exist regarding the mechanism of action of lipid emulsion, a combination of fatty acids traditionally used in parenteral nutrition. Some researchers attribute the effects to lipophilicity and the individual characteristics of the lipids, while other data demonstrate a direct empowering mechanism through cellular upstream and downstream pathways. Understanding the underlying mechanism of action of this safe source of calories may assist in the development of novel organ protective agents. In this review, some of the direct cardiac effects of lipid emulsion are briefly discussed.

 

This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

Downloads

Download data is not yet available.

Downloads

Published

2018-01-09

How to Cite

Motayagheni, N., Phan, S., Nozari, A., & Atala, A. (2018). Lipid Emulsion, More Than Reversing Bupivacaine Cardiotoxicity: Potential Organ Protection. Journal of Pharmacy & Pharmaceutical Sciences, 20(1), 329–331. https://doi.org/10.18433/J30D2V

Issue

Vol. 20 (2017): Pages 319-452

Section

Review Articles

License

This is an open access journal with free of charge non-commercial download. At the time of submission, authors will be asked to transfer the copyright to the accepted article to the Journal of Pharmacy and Pharmaceutical Sciences. The author may purchase the copyright for $500 upon which he/she will have the exclusive copyright to the article. Nevertheless, acceptance of a manuscript for publication in the Journal is with the authors' approval of the terms and conditions of the Creative Commons copyright license Creative Common license (Attribution-ShareAlike) License for non-commercial uses.

CLOCKSS system has permission to collect, preserve, and serve this Archival Unit.